Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.
Upasana Das AdhikariGeorge EngMara FarcasanuLaura E AvenaManish C ChoudharyVirginia A TriantMeaghan FlaggAbigail E SchiffIsabella GomezLeah M FroehleThomas J DiefenbachLarance RonsardDaniel LingwoodGrace C LeeSeyed Alireza RabiDerek ErstadGeorge VelmahosJonathan Z LiRichard HodinJames R StoneAnna N HonkoAnthony GriffithsOmer YilmazDouglas S KwonPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
The clinical significance of SARS CoV-2 RNA in stool remains uncertain. We found that extrapulmonary dissemination of infection to the gastrointestinal (GI) tract, assessed by the presence of SARS-CoV-2 RNA in stool, is associated with decreased COVID-19 survival. Measurement of SARS-CoV-2 RNA in stool may have utility for clinical risk assessment.